Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
暂无分享,去创建一个
G. Marfia | M. Lucchetta | G. Cavaletti | A. Schenone | L. Benedetti | C. Briani | G. Lauria | G. Cosentino | S. Cotti Piccinelli | M. Filosto | D. Cocito | L. Leonardi | M. Ceccanti | A. Mazzeo | V. Di Stefano | F. Manganelli | G. Liberatore | M. Luigetti | E. Spina | R. Fazio | L. Gentile | G. Antonini | E. Nobile‐Orazio | M. Carpo | E. Schirinzi | M. Campagnolo | Elisa Vegezzi | A. M. Clerici | G. Minicuci | P. Doneddu | M. Romozzi | T. Rosso | E. Peci | G. Mataluni | S. Matà | F. Germano | G. Siciliano | Maurizio Inghilleri | Houseyin Akyil | Camilla Strano
[1] Y. Rajabally,et al. Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] G. Marfia,et al. Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] R. Lewis,et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, European journal of neurology.
[4] M. Dentoni,et al. Atypical chronic inflammatory demyelinating polyradiculoneuropathy: recent advances on classification, diagnosis, and pathogenesis , 2021, Current opinion in neurology.
[5] R. Lewis,et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision , 2021, Journal of the peripheral nervous system : JPNS.
[6] G. Marfia,et al. Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? , 2020, European journal of neurology.
[7] S. Kuwabara,et al. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies , 2020, European journal of neurology.
[8] Jeffrey A. Allen. The Misdiagnosis of CIDP: A Review , 2020, Neurology and Therapy.
[9] B. Jacobs,et al. Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy , 2019, Journal of the peripheral nervous system : JPNS.
[10] G. Sobue,et al. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] D. Moher,et al. Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review , 2019, Journal of Neurology.
[12] G. Marfia,et al. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[13] D. Gelinas,et al. Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy , 2018, Brain and behavior.
[14] R. Lewis,et al. CIDP diagnostic pitfalls and perception of treatment benefit , 2015, Neurology.
[15] M. Mori,et al. Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[16] T. Maisonobe,et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy , 2010, Journal of the peripheral nervous system : JPNS.
[17] J. Pollard,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision , 2010, European journal of neurology.
[18] N. Gilhus,et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases , 2008, European journal of neurology.
[19] M. Donaghy,et al. Chronic dysimmune neuropathy , 2003, Journal of Neurology.
[20] M. Donaghy,et al. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. , 2003, Journal of neurology.